[Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
D000588:Amines / Q000378:metabolism; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects; D002415:Cats; D003641:Deamination; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects; D007980:Levodopa / Q000494:pharmacology; D008099:Liver / Q000187:drug effects; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014363:Tryptamines / Q000494:pharmacology; D014439:Tyramine / Q000378:metabolism
D000588:Amines; D007546:Isoquinolines; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D012701:Serotonin; D007980:Levodopa; D000661:Amphetamine; D014439:Tyramine
Issledovanie antimonoaminoksidaznogo deĭstviia i farmakologicheskikh svoĭstv gidrokhlorida 2,3-digidro-1H-benz[d,e]izokhinolina